Cancer Immunology

Cancer Immunology

The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributio...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Zhao, Xianda
Sonstige:
Subramanian, Subree
Zhao, Xianda
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (316 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545641404498
ctrlnum (CKB)5400000000042398
(oapen)https://directory.doabooks.org/handle/20.500.12854/77108
(EXLCZ)995400000000042398
collection bib_alma
record_format marc
spelling Subramanian, Subree edt
Cancer Immunology
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (316 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.
English
Medicine bicssc
NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
3-0365-2573-4
3-0365-2572-6
Zhao, Xianda edt
Subramanian, Subree oth
Zhao, Xianda oth
language English
format eBook
author2 Zhao, Xianda
Subramanian, Subree
Zhao, Xianda
author_facet Zhao, Xianda
Subramanian, Subree
Zhao, Xianda
author2_variant s s ss
x z xz
author2_role HerausgeberIn
Sonstige
Sonstige
title Cancer Immunology
spellingShingle Cancer Immunology
title_full Cancer Immunology
title_fullStr Cancer Immunology
title_full_unstemmed Cancer Immunology
title_auth Cancer Immunology
title_new Cancer Immunology
title_sort cancer immunology
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (316 p.)
isbn 3-0365-2573-4
3-0365-2572-6
illustrated Not Illustrated
work_keys_str_mv AT subramaniansubree cancerimmunology
AT zhaoxianda cancerimmunology
status_str n
ids_txt_mv (CKB)5400000000042398
(oapen)https://directory.doabooks.org/handle/20.500.12854/77108
(EXLCZ)995400000000042398
carrierType_str_mv cr
is_hierarchy_title Cancer Immunology
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1787548708811833344
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03966nam-a2201249z--4500</leader><controlfield tag="001">993545641404498</controlfield><controlfield tag="005">20231214132942.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000042398</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/77108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000042398</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Subramanian, Subree</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer Immunology</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (316 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NKG2D</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CAR T</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL-7</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prostate cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD19-CAR-T</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">B cell aplasia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KIR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inhibitory CAR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor-infiltrating lymphocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NK cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cells (CSCs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibody-dependent cellular cytotoxicity (ADCC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">differentiation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IFN-γ</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteoclasts</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MICA/B mAb</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">S-adenosylmethionine (SAM)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">innate immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adaptive immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">m6A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-L1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoints</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">combination immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TCR diversity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">organ transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epidemiologic studies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunosuppression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CTLA-4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Treg cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD28</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen-presenting cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL15</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colon cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uveal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BAP1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-PD-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-CTLA-4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TIL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">classical and endemic Kaposi Sarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systemic treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multi-state modelling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment free interval</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interferon</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triple negative breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunomodulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bispecific antibody</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sortase A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemo-enzymatic approach</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-CD20 antibody</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BiFab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dendritic cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Atypical Chemokine Receptor 4 (ACKR4)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T-cell priming</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">primary liver cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kynurenine pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune evasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">indoleamine 2,3 dioxygenase 1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tryptophan 2,3 dioxygenase 2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IDO inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen presenting cells</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2573-4</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2572-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xianda</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Subramanian, Subree</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xianda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:37:43 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338004980004498&amp;Force_direct=true</subfield><subfield code="Z">5338004980004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338004980004498</subfield></datafield></record></collection>

Similar Items